AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gluwin MV 1mg/500mg/0.3mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Ambrosia Pharmaceuticals

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Gluwin MV 1mg/500mg/0.3mg Tablet SR

Diabetace Control SR tablets (1mg/500mg/0.3mg) are categorized as antidiabetic agents, a combination medication for adult type 2 diabetes management. This medication helps regulate blood glucose. Diabetace Control SR should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive treatment plan encompassing diet, exercise, and weight management as advised by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Maintain regular mealtimes and carry a rapid-acting glucose source. Alcohol consumption should be limited due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Disclose any history of heart conditions to your physician before commencing treatment, as it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor. Regular blood sugar checks, along with blood cell and liver function tests as directed by your physician, are necessary.

Uses of Gluwin MV 1mg/500mg/0.3mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Gluwin MV 1mg/500mg/0.3mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Gluwin MV 1mg/500mg/0.3mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Gluwin MV 1mg/500mg/0.3mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Gluwin MV 1mg/500mg/0.3mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Gluwin MV 1mg/500mg/0.3mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume it on an empty stomach.

How Gluwin MV 1mg/500mg/0.3mg Tablet SR works:

Gluwin MV extended-release tablets (1mg/500mg/0.3mg) contain a triple-drug formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Gluwin MV 1mg/500mg/0.3mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Gluwin MV tablets (1mg/500mg/0.3mg) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the unborn. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Gluwin MV tablets (1mg/500mg/0.3mg) are likely unsafe for breastfeeding mothers. Available evidence in humans indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Gluwin MV 1mg/500mg/0.3mg SR tablets is likely inadvisable for individuals with impaired kidney function and should be forgone. Medical advice is necessary. Furthermore, its administration is discouraged in patients experiencing severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Gluwin MV 1mg/500mg/0.3mg Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A low initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; its use is contraindicated in those with severe liver disease.

What if you forget to take Gluwin MV 1mg/500mg/0.3mg Tablet SR :

Should you forget to take a Gluwin MV 1mg/500mg/0.3mg Tablet SR, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gluwin MV 1mg/500mg/0.3mg Tablet SR

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Gluwin MV 1mg/500mg/0.3mg Tablet SR

Gluwin MV 1mg/500mg/0.3mg Extended-Release tablets contain glimepiride, metformin, and voglibose. This triple-drug therapy manages type 2 diabetes mellitus in adults. Effective blood sugar control requires concomitant dietary modification and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin reduces hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, decreases post-meal glucose levels. This formulation is unsuitable for type 1 diabetes.
Gluwin MV 1mg/500mg/0.3mg sustained-release tablets may cause common adverse reactions including low blood glucose, queasiness, loose stools, taste disturbances, gas, abdominal discomfort, cephalalgia, dermatological reactions, and upper respiratory infections.
Patients with hypersensitivity to any Gluwin MV 1mg/500mg/0.3mg Tablet SR ingredient or inactive component should not take this medication. Similarly, its use is contraindicated in individuals with moderate to severe nephropathy, inflammatory bowel conditions, colonic ulcers, and metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol concurrently with Gluwin MV 1mg/500mg/0.3mg SR tablets is inadvisable. This combination may lead to dangerously low blood glucose (hypoglycemia) and heighten the risk of lactic acidosis.
Indeed, Gluwin MV 1mg/500mg/0.3mg SR tablets can induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. This risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, regular blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Retain this medication within its original, sealed packaging. Store as directed on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Gluwin MV 1mg/500mg/0.3mg...
72
MRP 88
18% off